PCRX vs ENTA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
PCRX
ENTA
Investment Advisor Scores
ENTA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | ENTA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.009 | 44.0529 | PCRX |
| PEG Ratio | 11.2121 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.0% | 15.0% | ENTA |
| Earnings Growth | -30.0% | -66.2% | PCRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.7/100 | 54.3/100 | PCRX |
| Profit Margin | 0.7% | -89.6% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (3.3% over 20 days), RSI 61
ENTA
DistributionPrice near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | PCRX | ENTA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | -6.2 |
| Trailing P/E | 207.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 0.8% | 1.0% |
| Operating Margin | 0.0% | -0.7% |
| EPS | 0.13 | -2.60 |
| Dividend Yield | — | — |